We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMIC
2726
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $230K | ﹤0.01% |
+1,213
| New | +$281K |
|
2727
Distribution Solutions Group
DSGR
$1.61B
| $226K | ﹤0.01% |
11,734
-248
| -2% | -$5.39K |
|
2728
Ceco Environmental
CECO
$4.14B
| $225K | ﹤0.01% |
40,918
-3,673
| -8% | -$21.5K |
|
2729
Harvard Bioscience
HBIO
$29.2M
| $225K | ﹤0.01% |
3,619
+1,152
| +47% | +$68.1K |
|
2730
Heritage Insurance Holdings
HRTG
$991M
| $225K | ﹤0.01% |
31,540
-3,619
| -10% | -$22.4K |
|
2731
Citius Pharmaceuticals
CTXR
$18.7M
| $223K | ﹤0.01% |
4,992
+833
| +20% | +$32.9K |
|
2732
Donegal Group Class A
DGICA
$714M
| $223K | ﹤0.01% |
16,607
-494
| -3% | -$6.9K |
|
2733
Kura Sushi USA
KRUS
$593M
| $221K | ﹤0.01% |
+4,011
| New | +$207K |
|
2734
Capital Bancorp
CBNK
$615M
| $218K | ﹤0.01% |
9,523
-985
| -9% | -$24.1K |
|
2735
Curis
CRIS
$7.83M
| $218K | ﹤0.01% |
229
+13
| +6% | +$16.6K |
|
2736
Fidelity D&D Bancorp
FDBC
$317M
| $218K | ﹤0.01% |
4,695
-492
| -9% | -$24.5K |
|
|
WEBR
2737
DELISTED
Weber Inc.
WEBR
| $217K | ﹤0.01% |
22,064
+8,809
| +66% | +$94.9K |
|
2738
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
| $216K | ﹤0.01% |
+2,800
| New | +$216K |
|
2739
Spero Therapeutics
SPRO
$73M
| $215K | ﹤0.01% |
24,740
+5,479
| +28% | +$56.1K |
|
2740
Lifetime Brands
LCUT
$211M
| $213K | ﹤0.01% |
16,573
-1,669
| -9% | -$23.2K |
|
2741
Aldeyra Therapeutics
ALDX
$93.5M
| $212K | ﹤0.01% |
47,596
+4,996
| +12% | +$19.9K |
|
|
NUVL
2742
DELISTED
Nuvalent
NUVL
| $211K | ﹤0.01% |
+15,205
| New | +$221K |
|
2743
Viemed Healthcare
VMD
$371M
| $211K | ﹤0.01% |
42,419
-3,846
| -8% | -$17.9K |
|
|
SPPI
2744
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $210K | ﹤0.01% |
162,991
-251,806
| -61% | -$232K |
|
2745
Global Water Resources
GWRS
$219M
| $209K | ﹤0.01% |
12,550
-157
| -1% | -$2.46K |
|
2746
Smith Micro Software
SMSI
$16.2M
| $209K | ﹤0.01% |
1,389
+114
| +9% | +$18K |
|
2747
HighPeak Energy
HPK
$910M
| $208K | ﹤0.01% |
+9,354
| New | +$184K |
|
2748
Oric Pharmaceuticals
ORIC
$1.4B
| $208K | ﹤0.01% |
38,871
+2,921
| +8% | +$26.3K |
|
2749
Precigen
PGEN
$2.59B
| $208K | ﹤0.01% |
98,545
-1,481
| -1% | -$3.61K |
|
2750
National CineMedia
NCMI
$378M
| $207K | ﹤0.01% |
8,151
-2,713
| -25% | -$75.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.